(INNS)
BELUDAVIMAB(INNC)
IMMUNOGLOBULIN G1-KAPPA, ANTI-[SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) SPIKE (S) GLYCOPROTEIN, RECEPTOR BINDING DOMAIN (RBD)], HOMO SAPIENS MONOCLONAL ANTIBODY; GAMMA1 HEAVY CHAIN HOMO SAPIENS (1-457) [VH (HOMO SAPIENS IGHV1-18*01 (92.9%) -(IGHD) -IGHJ5*01 (92.9%), CDR-IMGT [8.8.20] (26-33.51-58.97-116)) (1-127) -HOMO SAPIENS IGHG1*01, G1M17,1, G1V12 CH2 A1.1, L115, E117, G1V24 CH3 L107, S114 (CH1 K120 (224) (128-225), HINGE 1-15 (226-240), CH2 G1.1>A (246), A115>L (340), I117>E (342) (241-350), CH3 D12 (366), L14 (368), M107>L (438), N114>S (444) (351-455), CHS (456-457)) (128-457)], (230-214')- DISULFIDE WITH KAPPA LIGHT CHAIN HOMO SAPIENS (1'-214') [V-KAPPA (HOMO SAPIENS IGKV3-20*01 (93.7%) -IGKJ4*01 (100%), CDR-IMGT [7.3.8] (27-33.51-53.90-97)) (1'-107') -HOMO SAPIENS IGKC*01 (100%), KM3 A45.1 (153), V101 (191) (108'-214')]; DIMER (236-236'':239-239'')- BISDISULFIDE, PRODUCED IN A CHINESE HAMSTER OVARY (CHO)-K1 CELL LINE, GLYCOFORM ALFA(WHO)
BELUDAVIMABUM(INN)